Multiple congenital anomalies-hypotonia-seizures syndrome
muhl-ti-puhl kon-jen-i-tuhl uh-nom-uh-leez hy-po-toh-nee-uh see-zherz sin-drohm
Also known as: MCAHS, Fryns syndrome
At a Glance
What is Multiple congenital anomalies-hypotonia-seizures syndrome?
Multiple congenital anomalies-hypotonia-seizures syndrome is a rare genetic disorder that affects several body systems. It is characterized by the presence of multiple birth defects, low muscle tone (hypotonia), and seizures. The condition is caused by mutations in genes responsible for the biosynthesis of glycosylphosphatidylinositol (GPI), which is important for anchoring proteins to cell membranes. Over time, affected individuals may experience developmental delays and intellectual disabilities. Early symptoms often include feeding difficulties, weak muscle tone, and seizures, while later symptoms can involve more pronounced developmental challenges. Early diagnosis is critical to manage symptoms and improve quality of life. The condition can significantly impact family life, requiring ongoing medical care and support. Prognosis varies, but many individuals face lifelong challenges. Daily life for those affected often involves specialized therapies, educational support, and medical interventions. Families may need to adapt their routines to accommodate the needs of the affected individual. Support groups and resources can be beneficial for families. Overall, the condition requires a multidisciplinary approach to care.
Medical Definition
Multiple congenital anomalies-hypotonia-seizures syndrome is a genetic disorder caused by mutations in genes involved in the GPI-anchor biosynthesis pathway. Pathologically, it involves defects in the anchoring of proteins to cell membranes, affecting cellular communication and function. Histological findings may include abnormal neuronal migration and brain malformations. The syndrome is classified into different types based on the specific gene mutations, such as PIGA, PIGT, PIGP, and PIGN. Epidemiologically, it is an extremely rare condition with a low prevalence. The disease course is progressive, with symptoms evolving from early developmental issues to more complex neurological and systemic manifestations.
Multiple congenital anomalies-hypotonia-seizures syndrome Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Hypotonia manifests as decreased muscle tone, leading to floppiness and reduced resistance to passive movement. It is caused by disruptions in the neuromuscular pathways, often linked to genetic mutations affecting muscle control. Over time, hypotonia can lead to delays in motor skills and challenges in maintaining posture. Daily life is impacted by difficulties in activities requiring muscle strength, and physical therapy can help improve muscle tone and function.
Seizures present as sudden, uncontrolled electrical disturbances in the brain, causing changes in behavior, movements, or consciousness. They result from abnormal neuronal firing due to genetic mutations affecting ion channels or neurotransmitter pathways. Seizures can vary in frequency and severity, potentially becoming more frequent if not managed. They significantly impact daily life, requiring medication and sometimes lifestyle adjustments to manage triggers and ensure safety.
Multiple congenital anomalies are evident at birth and can include a range of physical malformations such as craniofacial abnormalities, limb defects, or organ malformations. These anomalies arise from genetic mutations affecting developmental pathways during embryogenesis. The progression depends on the specific anomalies present, with some requiring surgical intervention or ongoing medical management. They affect daily life by necessitating specialized medical care and potentially impacting physical and cognitive development.
Common
Developmental delay is characterized by slower than expected progression in achieving developmental milestones such as walking or talking. It is often due to neurological impairments caused by genetic mutations affecting brain development. Over time, the delay can become more pronounced if interventions are not implemented. Early intervention programs and therapies are crucial in supporting development and improving long-term outcomes.
Intellectual disability involves limitations in intellectual functioning and adaptive behaviors, affecting learning and problem-solving skills. It is caused by genetic mutations that impact brain development and function. The severity can vary, with some individuals showing mild impairments while others have more profound challenges. Daily life is affected by the need for special education and support services to aid learning and independence.
Feeding difficulties manifest as challenges in sucking, swallowing, or digesting food, often leading to poor weight gain. These difficulties are linked to hypotonia and neurological impairments affecting coordination of the muscles involved in feeding. Over time, they can lead to nutritional deficiencies and growth concerns if not addressed. Interventions such as feeding therapy and nutritional support are essential to ensure adequate intake and growth.
Less Common
Hearing loss can range from mild to profound and affects the ability to perceive sounds. It is caused by anomalies in the auditory system, potentially linked to genetic mutations affecting ear development. The progression can vary, with some cases remaining stable while others may worsen over time. Hearing aids or cochlear implants, along with speech therapy, can help improve communication and quality of life.
Vision problems may include issues such as strabismus, refractive errors, or more severe visual impairments. These problems arise from developmental anomalies in the eyes or visual pathways, often linked to genetic factors. The impact on vision can vary, with some conditions being correctable with glasses or surgery, while others may be more persistent. Regular eye examinations and appropriate corrective measures are important to optimize visual function and support development.
What Causes Multiple congenital anomalies-hypotonia-seizures syndrome?
Multiple congenital anomalies-hypotonia-seizures syndrome is primarily caused by mutations in genes involved in glycosylphosphatidylinositol (GPI) anchor biosynthesis, including PIGA, PIGT, PIGP, and PIGN, located on the X chromosome and autosomes. These genes encode proteins essential for the synthesis and attachment of GPI anchors to proteins, which are crucial for their localization and function on the cell surface. Mutations in these genes lead to defective GPI anchor biosynthesis, resulting in mislocalization and loss of function of GPI-anchored proteins. This disruption affects cell signaling, adhesion, and enzyme activities, leading to cellular dysfunction. Organelle dysfunction, particularly in the endoplasmic reticulum and Golgi apparatus, occurs due to the accumulation of misfolded proteins. Neighboring cells and tissues experience impaired communication and structural integrity, contributing to the clinical manifestations. Neuroinflammation is triggered by the accumulation of dysfunctional proteins and cellular stress, exacerbating neuronal damage. White matter degeneration occurs due to disrupted axonal transport and myelin sheath maintenance, leading to neurological symptoms. The specific pattern of symptoms, including seizures and hypotonia, arises from the selective vulnerability of neurons and muscle cells to GPI-anchor deficiencies. Variability in disease severity among patients is influenced by the type and location of mutations, as well as the presence of compensatory mechanisms in different individuals.
How is Multiple congenital anomalies-hypotonia-seizures syndrome Diagnosed?
Typical age of diagnosis: Diagnosis of Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome typically occurs in infancy or early childhood when developmental delays and seizures become apparent. Parents often notice hypotonia and feeding difficulties, prompting medical evaluation. Genetic testing is usually pursued after initial clinical assessments suggest a syndromic pattern. Early diagnosis is crucial for management and family planning.
Clinicians look for a combination of congenital anomalies, hypotonia, and seizures. A detailed family and prenatal history is crucial to identify any genetic predisposition or prenatal exposures. Physical examination may reveal dysmorphic features, muscle weakness, and developmental delays. This step helps in narrowing down the differential diagnosis and deciding on further investigations.
Magnetic Resonance Imaging (MRI) of the brain is commonly used to assess structural abnormalities. Specific findings may include cortical malformations or other brain anomalies that support the diagnosis. These imaging results help confirm the diagnosis by correlating clinical findings with structural brain changes. Imaging also helps exclude other conditions like isolated epilepsy or cerebral palsy.
Metabolic screening tests are ordered to rule out inborn errors of metabolism. Biomarkers such as elevated lactate or ammonia levels may indicate metabolic disturbances. Abnormal results prompt further metabolic or genetic testing to clarify the diagnosis. Laboratory findings guide clinicians towards specific genetic tests and management strategies.
Next-generation sequencing is used to analyze genes such as PIGA, PIGT, PIGP, and PIGN. Mutations like missense, nonsense, or frameshift variants are identified. These results confirm the diagnosis by correlating specific genetic mutations with the clinical syndrome. Genetic findings are essential for family counseling regarding recurrence risks and potential prenatal diagnosis.
Multiple congenital anomalies-hypotonia-seizures syndrome Treatment Options
Antiepileptic drugs (AEDs) such as valproate and levetiracetam are commonly used. These drugs work by stabilizing neuronal membranes and reducing excitability. Clinical trials have shown efficacy in reducing seizure frequency in affected individuals. However, side effects like sedation and liver toxicity can limit their use. Regular monitoring of drug levels and liver function tests is necessary.
Techniques such as stretching, strengthening, and motor skills training are employed. The goal is to improve muscle tone, coordination, and overall motor function. Sessions are typically conducted 2-3 times a week for optimal outcomes. Measurable outcomes include improved muscle strength and motor milestones. Long-term benefits include enhanced mobility and quality of life.
Surgery may be indicated for severe musculoskeletal deformities. Procedures such as tendon release or spinal fusion can be performed. Expected benefits include improved posture and mobility. Surgical risks include infection and anesthesia complications. Post-operative care involves rehabilitation and monitoring for complications.
The care team includes neurologists, geneticists, physiotherapists, and social workers. Interventions focus on seizure management, nutritional support, and developmental therapies. Psychosocial support strategies involve counseling and support groups for families. Family education includes training on seizure management and developmental expectations. Long-term monitoring involves regular follow-ups to adjust care plans as needed.
When to See a Doctor for Multiple congenital anomalies-hypotonia-seizures syndrome
- Severe seizures — Immediate medical attention is required as they can lead to brain damage or be life-threatening.
- Respiratory distress — This is an emergency because it can quickly lead to inadequate oxygen supply to the body.
- Loss of consciousness — This can indicate a severe neurological event and requires urgent evaluation.
- Frequent mild seizures — These may indicate worsening of the condition and require a medical review.
- Progressive muscle weakness — This could signify disease progression and should be evaluated by a healthcare professional.
- Developmental delays — Early intervention is crucial, so consult a specialist if delays are noticed.
- Mild hypotonia — Monitor muscle tone at home and consult a doctor if it worsens.
- Occasional mild tremors — Keep track of frequency and duration, and discuss with a doctor during regular check-ups.
Multiple congenital anomalies-hypotonia-seizures syndrome — Frequently Asked Questions
Is this condition hereditary?
Multiple congenital anomalies-hypotonia-seizures syndrome is typically inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell have mutations. Parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they usually do not show signs and symptoms of the condition. De novo mutations can occur, but they are less common. Carrier parents have a 25% chance of passing the condition to their children with each pregnancy. Genetic counseling is recommended for affected families to understand the risks and implications.
What is the life expectancy for someone with this condition?
Life expectancy can vary significantly depending on the severity and management of symptoms. Early onset and severe manifestations often correlate with a poorer prognosis. Respiratory complications and severe neurological impairments are common causes of mortality. Effective management of symptoms and supportive care can improve quality of life and potentially extend survival. Families should have realistic expectations and work closely with healthcare providers to optimize care.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves a combination of clinical evaluation, genetic testing, and consultation with specialists such as neurologists and geneticists. The time from first symptoms to diagnosis can vary, often taking several months due to the rarity and complexity of the condition. Delays are common due to overlapping symptoms with other disorders and limited awareness among healthcare providers. Genetic testing confirms the diagnosis by identifying mutations in relevant genes. Early recognition and referral to specialized centers can expedite the diagnostic process.
Are there any new treatments or clinical trials available?
Research is ongoing, with gene therapy and other novel approaches being explored as potential treatments. Clinical trials can be found on ClinicalTrials.gov, where patients and families can search for opportunities to participate. It is important to discuss with your doctor whether any trials are suitable and what the potential risks and benefits are. While promising, new treatments may take years to become widely available. Staying informed about research developments is crucial for accessing emerging therapies.
How does this condition affect daily life and activities?
The condition can significantly impact mobility and self-care, often requiring assistive devices and adaptations. Educational challenges are common, necessitating individualized learning plans and support. Social and emotional challenges may arise due to physical limitations and communication difficulties. The condition places a considerable burden on families, who may need to coordinate care and support services. Access to occupational therapy, special education resources, and support groups can greatly enhance quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Paroxysmal nocturnal hemoglobinuria.
Brodsky RA · Blood · 2014 · PMID: 25237200
- 2.Spectrum of Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 3 (MCAHS3) Due to Phosphatidylinositol Glycan Biosynthesis Class T (PIGT) Gene Mutations: A Narrative Review.
Ranjan A, Alam MS, Kumar V et al. · Cureus · 2024 · PMID: 38903302
- 3.The correlation between multiple congenital anomalies hypotonia seizures syndrome 2 and PIGA: a case of novel PIGA germline variant and literature review.
Liu X, Meng J, Ma J et al. · Mol Biol Rep · 2022 · PMID: 36116096
- 4.[Multiple congenital anomalies-hypotonia-seizures syndrome 1: case report and review of literature].
Xu YF, Li N, Li GQ et al. · Zhonghua Er Ke Za Zhi · 2017 · PMID: 28273706
- 5.Rare multiple congenital anomalies-hypotonia-seizures syndrome type 1 (MCAHS1) - the clinical and molecular summary.
Bukowska-Olech E, Glista F, Dinwiddie A et al. · Eur J Med Genet · 2023 · PMID: 36384198
- 6.Expanding the phenotype of PIGP deficiency to multiple congenital anomalies-hypotonia-seizures syndrome.
Martín-Grau C, Orellana Alonso C, Roselló Piera M et al. · Clin Genet · 2023 · PMID: 37125481
- 7.PIGN mutation multiple congenital anomalies-hypotonia-seizures syndrome 1: A case report.
Hou F, Shan S, Jin H · World J Clin Cases · 2022 · PMID: 35812661
- 8.Biallelic variants in PIGN cause Fryns syndrome, multiple congenital anomalies-hypotonia-seizures syndrome, and neurologic phenotypes: A genotype-phenotype correlation study.
Loong L, Tardivo A, Knaus A et al. · Genet Med · 2023 · PMID: 36322149
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-28